Airsculpt Technologies, Inc. (AIRS) stock
AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3083% below fair value
$0.72−0.02 (-2.80%)
Close on Nov 18, 2026Market cap $51.76MP/E –Yield –
Airsculpt Technologies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Airsculpt Technologies's operating income for the twelve months ending Jun 30, 2026 was -$12.59M. For fiscal 2025 it was -$11.56M. The highest annual figure on record is $15.77M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.56M | – |
| FY2024 | Dec 31, 2024 | -$1.58M | -116.3% |
| FY2023 | Dec 31, 2023 | $9.72M | – |
| FY2022 | Dec 31, 2022 | -$4.55M | -128.8% |
| FY2021 | Dec 31, 2021 | $15.77M | +57.2% |
| FY2020 | Dec 31, 2020 | $10.03M | +1413.3% |
| FY2019 | Dec 31, 2019 | $663.00K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$29.00K | -103.7% |
| Q1 FY2026 | Mar 31, 2026 | -$1.80M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.01M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.75M | – |
| Q2 FY2025 | Jun 30, 2025 | $786.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.59M | -114.4% |
| Q4 FY2024 | Dec 31, 2024 | -$3.90M | -337.2% |
| Q3 FY2024 | Sep 30, 2024 | -$3.72M | -489.1% |
| Q2 FY2024 | Jun 30, 2024 | -$4.98M | -192.9% |
| Q1 FY2024 | Mar 31, 2024 | $11.01M | +525.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.64M | – |
| Q3 FY2023 | Sep 30, 2023 | $955.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $5.36M | +35.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.76M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.96M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.38M | -114.3% |
| Q2 FY2022 | Jun 30, 2022 | $3.96M | -64.6% |
| Q1 FY2022 | Mar 31, 2022 | -$1.17M | -116.2% |
| Q4 FY2021 | Dec 31, 2021 | -$12.26M | – |
| Q3 FY2021 | Sep 30, 2021 | $9.62M | – |
| Q2 FY2021 | Jun 30, 2021 | $11.20M | – |
| Q1 FY2021 | Mar 31, 2021 | $7.21M | – |
See a number that looks wrong?